Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank72
3Y CAGR+68.3%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+68.3%/yr
Quarterly compound
Percentile
P72
Within normal range
vs 3Y Ago
4.8x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.30% |
| Q3 2025 | 39.48% |
| Q2 2025 | 8.47% |
| Q1 2025 | 0.30% |
| Q4 2024 | -0.12% |
| Q3 2024 | -0.07% |
| Q2 2024 | 4.67% |
| Q1 2024 | -0.11% |
| Q4 2023 | 0.98% |
| Q3 2023 | -0.11% |
| Q2 2023 | -0.12% |
| Q1 2023 | -0.01% |
| Q4 2022 | 1.53% |
| Q3 2022 | 128.05% |
| Q2 2022 | 0.58% |
| Q1 2022 | 19.36% |
| Q4 2021 | 1.35% |
| Q3 2021 | 6.24% |
| Q2 2021 | 9.80% |
| Q1 2021 | 64.33% |
| Q4 2020 | -1.10% |
| Q3 2020 | 1.77% |
| Q2 2020 | 0.32% |
| Q1 2020 | 1.13% |
| Q4 2019 | 158.70% |
| Q3 2019 | -1.33% |
| Q2 2019 | 1.80% |
| Q1 2019 | 23.46% |
| Q4 2018 | 1.21% |
| Q3 2018 | 29.48% |
| Q2 2018 | 1.29% |
| Q1 2018 | 0.56% |
| Q4 2017 | 55.23% |
| Q3 2017 | -10.39% |
| Q2 2017 | -9.33% |
| Q1 2017 | -7.98% |
| Q4 2016 | -7.94% |
| Q3 2016 | 0.47% |
| Q2 2016 | 0.47% |
| Q1 2016 | 101.28% |